Brain Burdens of Aluminum, Iron, and Copper and their Relationships with Amyloid-β Pathology in 60 Human Brains
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The deposition in the brain of amyloid-β as beta sheet conformers associated with senile plaques and vasculature is frequently observed in Alzheimer’s disease. While metals, primarily aluminum, iron, zinc, and copper, have been implicated in amyloid-β deposition in vivo, there are few data specifically relating brain metal burden with extent of amyloid pathologies in human brains. Herein brain tissue content of aluminum, iron, and copper are compared with burdens of amyloid-β, as senile plaques and as congophilic amyloid angiopathy, in 60 aged human brains. Significant observations were strong negative correlations between brain copper burden and the degree of severity of both senile plaque and congophilic amyloid angiopathy pathologies with the relationship with the former reaching statistical significance. While we did not have access to the dementia status of the majority of the 60 brain donors, this knowledge for just 4 donors allowed us to speculate that diagnosis of dementia might be predicted by a combination of amyloid pathology and a ratio of the brain burden of copper to the brain burden of aluminum. Taking into account only those donor brains with either senile plaque scores ≥4 and/or congophilic amyloid angiopathy scores ≥12, a Cu:Al ratio of <20 would predict that at least 39 of the 60 donors would have been diagnosed as suffering from dementia. Future research should test the hypothesis that, in individuals with moderate to severe amyloid pathology, low brain copper is a predisposition to developing dementia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In plaques from persons with Alzheimer’s disease, iron and aluminum appear to cause plaque formation while copper and zinc may be protective [26,27,28,35,36,37].”
From The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline (2017) · cites this paper as [27]
Citations
Cites
The prevalence of dementia: A quantitative integration of the literature
Jorm, A. F., Korten, A. E., & Henderson, A. S. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02906.x · Cited by 1,296
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900 · cited 4×
“In their published studies CFAS were unable to relate SP pathologies with dementia status as the non-demented very old showed similar levels of SP to demented younger donors [20, 21].”
InfluentialCerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Vinters, H. V., & Gilbert, J. J. (1983) · Stroke · doi:10.1161/01.str.14.6.924 · Cited by 504
Copper in the brain and Alzheimer’s disease
Hung, Y. H., Bush, A. I., & Cherny, R. A. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0600-y · Cited by 498
House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294
Self-citationOlichney, J. M., Hansen, L. A., Hofstetter, C. R., Grundman, M., Katzman, R., & Thal, L. J. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310076019 · Cited by 246
Yamaguchi, H., Yamazaki, T., Lemere, C. A., Frosch, M. P., & Selkoe, D. J. (1992) · PubMed · Cited by 216
BORCHARDT, T., CAMAKARIS, J., CAPPAI, R., MASTERS, C. L., BEYREUTHER, K., & MULTHAUP, G. (1999) · Biochemical Journal · doi:10.1042/bj3440461 · Cited by 171
Ikeda, S., Allsop, D., & Glenner, G. G. (1989) · PubMed · Cited by 156
Cited by
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
“Iron can directly promote amyloid-b aggregation (House et al., 2004; Schubert and Chevion, 1995) and iron levels can modulate amyloid precursor protein pathways (Exley et al., 2012; Silvestri and Camaschella, 2008).”
Willhite, C. C., Karyakina, N. A., Yokel, R. A., Yenugadhati, N., Wisniewski, T. M., Arnold, I. M. F., Momoli, F., & Krewski, D. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.934439 · Cited by 412
“Controversy over what constitutes “safe” Al exposure began at least 100 years ago (Gies 1911) and questions persist concerning the role of Al in AD (Campdelacreu 2012, Exley et al. 2012, Tomljenovic 2011, Solfrizzi et al. 2011, Walton 2012a) and other disease states (AFSSAPS 2011).”
BackgroundResultThe essential elements of Alzheimer’s disease
Lei, P., Ayton, S., & Bush, A. I. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.008207 · Cited by 327
Bondy, S. C. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2015.12.002 · Cited by 263
“However, AD is also associated with other metal imbalances such as major depression of copper levels and the issue of causality remains elusive (Akatsu et al., 2012; Exley et al., 2012).”
Aluminium in brain tissue in familial Alzheimer’s disease
Mirza, A., King, A., Troakes, C., & Exley, C. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.12.001 · Cited by 261
Self-citationRole of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
Bagheri, S., Squitti, R., Haertlé, T., Siotto, M., & Saboury, A. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00446 · Cited by 221
“The involvement of copper in AD is controversial, as some studies show copper deficiency in AD, and consequently a need to enhance copper levels (Borchardt et al., 1999; Kessler et al., 2005, 2008a,b; Exley, 2006; Jiao and Yang, 2007; Vural et al., 2010; Kaden et al., 2011; Exley et al., 2012), while other data point…”
BackgroundRamos, P., Santos, A., Pinto, N. R., Mendes, R., Magalhães, T., & Almeida, A. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2013.08.001 · Cited by 221
Bondy, S. C. (2014) · Toxicology · doi:10.1016/j.tox.2013.10.008 · Cited by 177
Cerebral Iron Deposition in Neurodegeneration
Dusek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. O. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 159
Everett, J., Céspedes, E., Shelford, L. R., Exley, C., Collingwood, J. F., Dobson, J., van der Laan, G., Jenkins, C. A., Arenholz, E., & Telling, N. D. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0165 · Cited by 151
Self-citationCopper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
Ejaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 143
“Cu concentration of the elderly has a direct relation with Aβ aggregation [86].”
BackgroundExley, C., & Clarkson, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-64734-6 · Cited by 137
Self-citationWhat is the risk of aluminium as a neurotoxin?
Exley, C. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.915745 · Cited by 102
Self-citationMold, M., Ouro-Gnao, L., Wieckowski, B. M., & Exley, C. (2013) · Scientific Reports · doi:10.1038/srep01256 · Cited by 101
Self-citationSzabo, S. T., Harry, G. J., Hayden, K. M., Szabo, D. T., & Birnbaum, L. S. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv325 · Cited by 98
β‐Amyloid aggregation and heterogeneous nucleation
Srivastava, A. K., Pittman, J. M., Zerweck, J., Venkata, B. S., Moore, P. C., Sachleben, J. R., & Meredith, S. C. (2019) · Protein Science · doi:10.1002/pro.3674 · Cited by 81
Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation
Aaseth, J., Alexander, J., Bjørklund, G., Hestad, K. A., Dušek, P., Roos, P. M., & Alehagen, U. (2016) · BioMetals · doi:10.1007/s10534-016-9959-8 · Cited by 79
“From Spain GonzalezDomınguez et al. (2014) in a cross sectional study found lower Se levels in serum from AD patients (121 lg/L) in comparison to elderly MCI subjects (127 lg/L) (Gonzalez-Dominguez et al. 2014).”
Pickart, L., Vasquez-Soltero, J., & Margolina, A. (2017) · Brain Sciences · doi:10.3390/brainsci7020020 · Cited by 51
Shen, X., Yu, J., Zhang, D., Xie, J., & Jiang, H. F. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140153 · Cited by 57
Wang, D., Hui, Y., Peng, Y., Tang, L., Jin, J., He, R., Li, Y., Zhang, S., Li, L., Zhou, Y. L., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140567 · Cited by 51
Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer’s Disease with 7T MR
Tiepolt, S., Bank, N. B., Schäfer, A., Rullmann, M., Roggenhofer, E., Gertz, H., Schroeter, M. L., Patt, M., Bazin, P., Jochimsen, T. H., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180118 · Cited by 50
The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light
Collingwood, J. F., & Davidson, M. R. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00191 · Cited by 49
“This observation was reinforced in study of 60 aged human brains, where it was demonstrated that there is no relationship between tissue iron concentration and congophilic amyloid angiopathy or senile plaque burden (Exley et al., 2012).”
ResultScholefield, M., Church, S. J., Xu, J., Patassini, S., Roncaroli, F., Hooper, N. M., Unwin, R. D., & Cooper, G. J. S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.641222 · Cited by 49
Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
Gámez, P., & Caballero, A. B. (2015) · AIP Advances · doi:10.1063/1.4921314 · Cited by 38
Mohammed, R. S., Ibrahim, W., Sabry, D., & El-Jaafary, S. I. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.09.017 · Cited by 37
Aluminum and Neurodegenerative Diseases
Bondy, S. C., & Campbell, A. (2017) · Advances in neurotoxicology · doi:10.1016/bs.ant.2017.07.008 · Cited by 39
“For instance, AD has also been associated with other metal imbalances such as abnormal copper levels, but the establishment of a causal relation remains unresolved (Akatsu et al., 2012; Exley et al., 2012; Kitazawa et al., 2009).”
BackgroundWang, Q., Jiang, H., Wang, L., Yi, H., Li, Z., & Liu, R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190640 · Cited by 28
Bumblebee Pupae Contain High Levels of Aluminium
Exley, C., Rotheray, E. L., & Goulson, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127665 · Cited by 31
Self-citationCopper homeostasis and cuproptosis in Alzheimer's disease (Review)
Cong, C., Cong, H., Yao, Y., Bai, Y., & Xu, L. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5613 · Cited by 36
Kumar, N., Thorat, S. T., Gite, A., & Patole, P. B. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03575-6 · Cited by 20
“Copper deficiency may be disturbing copper homeostasis, enhance the labile pool of Cu, and decrease the amount of Cu bound to protein [89, 90].”
BackgroundXu, Y., Zhang, H., Pan, B., Zhang, S., Wang, S., & Niu, Q. L. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9879-1 · Cited by 19
“Epidemiological studies have shown that high-level Al exposure could seriously impair human neural functions (Bondy 2010), while low-level and long-term Al exposure has been linked with some neurodegenerative disorders such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis, dementia, and parkinsonism (Bondy 2…”
BackgroundKumar, N., Singh, A., Kumar, S. S., Kumar, T., Kochewad, S. A., Thorat, S. T., Patole, P. B., & Gite, A. (2022) · Aquaculture · doi:10.1016/j.aquaculture.2022.739059 · Cited by 16
miR-200a-3p Regulates PRKACB and Participates in Aluminium-Induced Tau Phosphorylation in PC12 Cells
Li, H., Liu, Q., Zhang, Q., Xue, X., Zhang, J., Zhang, J., Lin, L., & Niu, Q. L. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00609-0 · Cited by 12
“However, the molecular mechanism of its toxicity is not completely understood and its neurotoxic mechanism requires further study (Exley et al. 2012; Yasui et al. 1992; Alfrey et al. 1976).”
BackgroundCendrowska‐Pinkosz, M., Krauze, M., Juśkiewicz, J., & Ognik, K. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126777 · Cited by 12
Hayden, M. R., & Tyagi, N. (2024) · Pharmaceuticals · doi:10.3390/ph17121741 · Cited by 13
Demirel, G., Sanajou, S., Yirün, A., Çakır, D. A., Berkkan, A., Baydar, T., & Erkekoğlu, P. (2023) · Journal of Applied Toxicology · doi:10.1002/jat.4564 · Cited by 18
“Various studies investigated the pathways of Al-induced neurotoxicity, such as oxidative stress injury, DNA damage, and mitochondrial dysfunction (Exley et al., 2012; Sanajou, Erkeko (cid:1) glu, et al., 2023).”
BackgroundMetaxas, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.755475 · Cited by 13
“…a need for supplementation (Borchardt et al., 1999; Exley, 2006; Jiao and Yang, 2007; Kessler et al., 2008; Vural et al., 2010; Kaden et al., 2011; Exley et al., 2012; Xu et al., 2017), while others indicate copper excess in AD, suggesting a need for chelating agents (Cherny et al., 2001; Sparks…”
BackgroundMagrì, A. L., Mendola, D. L., & Rizzarelli, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105085 · Cited by 11
“Studies show copper deficiency in patients affected by AD, and consequently a need to enhance copper levels so to restore normal metal concentration [33,34]; differently, other experiments point to metal overload and consequent demand to reduce copper concentration [35,36].”
BackgroundSchreurs, B. G., & Sparks, D. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150601 · Cited by 10
“The ubiquitous nature of aluminum both in manufactured products as well as in nature have prompted many to examine and discuss its toxic nature especially as it relates to AD [10, 11, 51, 55, 77, 78].”
Tian, B., Cheng, C., Yue, T., Lin, N., & Ren, H. (2018) · Chemical Physics · doi:10.1016/j.chemphys.2018.06.006 · Cited by 7
Crosstalk between copper, Alzheimer’s disease, and melatonin
Deepika, Thakur, A., Panghal, A., Pundir, R., Singh, C., Goyal, M., Namdeo, A. G., & Kumar, J. (2025) · BioMetals · doi:10.1007/s10534-025-00712-7 · Cited by 9
“At the same time, some studies suggest a correlation between AD manifestation and copper deficiency (Exley et al. 2012; Kaden et al. 2011; Vural et al. 2010; Xu et al. 2017).”
Cunliffe, G., Lim, Y. T., Chae, W., & Jung, S. (2022) · Biomedicines · doi:10.3390/biomedicines10123064 · Cited by 7
Bathla, M., Saini, T. C., Teji, N., Randhawa, S., Bhardwaj, R., & Acharya, A. (2025) · Small · doi:10.1002/smll.202508683 · Cited by 4
Kumar, G., Srivastava, A., Kumar, P., Srikrishna, S., & Singh, V. P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24074 · Cited by 5
“The role of copper in AD is controversial, as in few reports deficiency of copper was observed in AD brain [15 – 17].”
BackgroundA facile approach to create sensitive and selective Cu( ii ) sensors on carbon fiber microelectrodes
Nudurupati, U., Narla, T., Punihaole, D., & Ou, Y. (2023) · RSC Advances · doi:10.1039/d3ra05119f · Cited by 6
Impact of aging on copper isotopic composition in the murine brain
Lahoud, E., Moynier, F., Luu, T.-H., Mahan, B., & Borgne, M. L. (2024) · Metallomics · doi:10.1093/mtomcs/mfae008 · Cited by 4
Shoeb, M., Alman, B. L., Kaur, H., Han, M., Atif, F., Kim, W. W., Desai, S., Ruiz, P., & Zarus, G. M. (2026) · Genes · doi:10.3390/genes17020236 · Cited by 7
Copper in human health: From COVID 19 to neurodegenerative diseases
Deloncle, R., Guillard, O., & Pineau, A. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127636 · Cited by 6
Deloncle, R. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115812 · Cited by 2
Treatment of Neurodegenerative Diseases by Chelators
Ward, R. J., Dexter, D. T., & Crichton, R. R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623892-00153 · Cited by 2
Deloncle, R., Fauconneau, B., Guillard, O., Delaval, J., Lesage, G., & Pineau, A. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.07.006 · Cited by 2
Antioxidant Status in Paranoid Schizophrenia and Alzheimer’s Disease
Sokolova, S. V., Sozarukova, M. M., Khannanova, A. N., Grishina, N. K., Portnova, G. V., & Proskurnina, E. V. (2021) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-021-01052-y · Cited by 1
Szpoganicz, B. P., Probst, L. F. D., Costa, T. G., Meurer, L., & Szpoganicz, B. (2023) · Chemistry of Inorganic Materials · doi:10.1016/j.cinorg.2023.100028 · Cited by 1
Arguments from Correlation to Causation
Walton, D. (2015) · Law, governance and technology series · doi:10.1007/978-3-319-19626-8_6 · Cited by 1
Antioxidant status in patients with paranoid schizophrenia and Alzheimer disease
Sokolova, S. V., Sozarukova, M. M., Khannanova, A. N., Grishina, N. K., Portnova, G. V., & Proskurnina, E. V. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012006182 · Cited by 2
Belliardo, C. (2018) · theses.fr (ABES) · doi:10.70675/468f60e4zb8cez4669za33az83fd49317a6f · Cited by 1
Alushaj, E. (2019) · Scholarship@Western (Western University) · Cited by 1
Omar, S. H. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-7327-7_1 · Cited by 2
Ramos, P., Santos, A., Pinto, N. R., Mendes, R. P., Magalhães, T., & Almeida, A. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Metadata
- Authors
- Exley, C., House, E., Polwart, A., & Esiri, M. M.
- Affiliations
- Keele University (GB)
- John Radcliffe Hospital (GB)
- Corresponding author
- Exley, Christopher
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2012-09-11
- Volume
- 31
- Issue
- 4
- Pages
- 725-730
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1880679495
- Cited by
- 59
- References
- 19
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 2 · 2016: 4 · 2015: 7 · 2014: 7 · 2013: 3
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Chinese Academy of Agricultural Sciences
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid-beta, amyloid plaques
- MeSH terms
- Aged, Aged, 80 and over, Aluminum, Alzheimer Disease, Body Burden, Brain, Brain Chemistry, Copper, Dementia, Female, Humans, Iron, Male, Biomarkers, Amyloid beta-Peptides, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.